
    
      The primary objective of this study is to evaluate the impact of TK3 on the quality of life
      of patients receiving anti-neoplastic chemotherapy. The secondary objectives are to evaluate
      the influence of TK3 on the side effects caused by anti-neoplastic chemotherapy, tolerance to
      this treatment and the safety of the use of the TK3 product in cancer patients, accompanying
      the appearance of non-characteristic effects of the existing cancer type .
    
  